Day: December 30, 2019

  CGG Exits from Seabed Data Acquisition Business

CGG Arrête son Activité d’Acquisition de Données Fond de Mer Paris, 30 décembre 2019 — CGG annonce ce jour avoir finalisé la sortie définitive de son activité d’acquisition de données sismiques fond de mer et mis fin à son accord d’actionnariat dans la joint-venture Seabed Geosolutions (SBGS) et ce à compter du 31 décembre 2019.En accord avec sa stratégie de sortie des activités d’acquisition de données sismiques, CGG a signé un accord pour transférer sa participation de 40% dans la joint-venture Seabed Geosolutions vers Fugro d’ici à la fin du premier trimestre 2020 et pour finaliser les différents sujets de financement de SBGS et de non concurrence en payant $35 millions...

GG St. Kongensgade 100 og 106 P/SNasdaq First North, Copenhagen, Bond MarketTicker:  GGKONG; ISIN: DK0030444401For release: 30 December 2019Change of Turn-Key ContractorHarder Elements A/S (the Contractor) and GG St. Kongensgade 100 og 106 P/S (the Issuer) has on the 29th December 2019 mutually agreed to cancel the turn-key contract for the conversion of St. Kongensgade 100 and 106 properties into student apartments, family apartments and a supermarket as the Contractor is no longer in a position to fulfill its contractual obligations. On 29th December 2019 the Issuer has furthermore signed a new turn-key contract with Jeppesen Byggeri & Service ApS to complete the ongoing conversion of the properties. The new turn-key contract is similar to the cancelled contract including assignment of similar rights and securities to the...

Raisio plc      Stock Exchange Release, 30 December 2019RAISIO’S CONVERTED SHARESThe Board of Directors of Raisio plc has decided in its meeting held on 12 December 2019 to convert a total of 58,902 restricted shares (series K) into free shares (series V). The decision has been entered in the Trade Register today, on 30 December 2019. The additional lot of free shares in question is admitted to trading on the Nasdaq Helsinki Ltd as of 2 January 2020.Since the beginning of 2019, a total of 336,202 restricted shares of the company have been converted into free shares. The number of issued free shares is now 133,694,062 while the number of restricted shares is 31,454,968. The share capital entitles to 762,793,422 votes.Since the conversion occurs between the two share classes, it does not affect the company’s...

Raisio Oyj     Pörssitiedote 30.12.2019RAISION MUUNNETUT OSAKKEETRaisio Oyj:n hallitus on 12.12.2019 pitämässään kokouksessa päättänyt muuntaa 58.902 kantaosaketta (sarja K) vaihto-osakkeiksi (sarja V). Päätös on tänään 30.12.2019 merkitty kaupparekisteriin. Kyseinen vaihto-osakkeiden lisäerä otetaan kaupankäynnin kohteeksi Nasdaq Helsinki Oy:n arvopaperipörssissä 2.1.2020 alkaen.Yhtiön kantaosakkeita on vuoden 2019 alusta lukien muunnettu vaihto-osakkeiksi yhteensä 336.202 kappaletta. Yhtiön liikkeeseen laskemien vaihto-osakkeiden määrä on nyt 133.694.062 kappaletta ja kantaosakkeiden määrä 31.454.968 kappaletta. Osakekanta tuottaa 762.793.422 ääntä.     ...

YERINGTON, Nev., Dec. 29, 2019 (GLOBE NEWSWIRE) — Nevada Copper Corp. (TSX: NCU) (“Nevada Copper” or the “Company’’) is pleased to announce the identification of multiple new copper targets at its Pumpkin Hollow Project and the intersection of shallow copper mineralization of grades up to 0.9% Cu in structural reconnaissance drill results, including indicators of a potential porphyry-style target and grab samples as high as 6.2% Cu at surface.Exploration Program Highlights:Significant expansion and consolidation of strong land position in re-emerging copper camp: Increased land holdings by over 30%, adding over 5,700 hectares to Nevada Copper’s strong land position;Identification of multiple new copper targets: Multiple targets have been identified across Company’s land holdings, including...

Regulated informationGosselies, Belgium, 30 December 2019, 7am CET – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative cell and biological therapies to address high unmet medical needs in orthopaedics and bone diseases, today announces an increase in the total number of voting rights and shares as a result of the issuance of new shares on 18 December 2019 following the conversion of convertible bonds issued on the private placement on 7 March 2018. The following information is published in accordance with Article 15 of the Belgian Law of 2 May 2007 on the publication of major shareholdings in issuers whose shares are admitted to trading on regulated market.(1) On 12 December 2019, the Extraordinary General Shareholders Meeting approved...

Information réglementéeGosselies, Belgique, le 30 décembre 2019, 07h00 CET – BONE THERAPEUTICS (code Euronext Bruxelles et Paris : BOTHE), société de biotechnologie spécialisée dans le développement de thérapies cellulaires et biologiques innovantes répondant à d’importants besoins médicaux non satisfaits dans les domaines de l’orthopédie et des maladies osseuses, annonce aujourd’hui une augmentation du nombre total de droits de vote et d’actions suite à l’émission de nouvelles actions le 18 décembre 2019. L’émission des nouvelles actions est le résultat de la conversion des obligations convertibles émises dans le cadre d’un placement privé...